Preventable deaths occur because medicines used to treat life-threatening conditions are often not available or of poor quality. See how the U.S. Agency for International Development and USP worked to build stronger medicines quality assurance systems in Nigeria.
Shortages in quality-assured medicines impede efforts to reduce the prevalence of tuberculosis, malaria, and HIV/AIDS, and undermine progress in maternal and child health. Investments that build capacity of local manufacturers to produce medicines according to international quality standards and help bring low-cost, essential medicines to markets and patients faster are urgently needed.
USP collaborates with USAID, WHO, and other partners to increase the supply of priority, quality-assured, essential medicines. Our technical assistance helps companies build stronger quality-assurance systems and satisfy regulatory requirements for marketing authorization and procurement.
Areas of Technical Support & Training
- Active pharmaceutical ingredient and product development
- Technology transfer
- Process scale up
- Dossier compilation
- Good Manufacturing Practices
- WHO prequalification and Stringent Regulatory Authority (SRA) approval
- Provision of public standards